Beaumont Financial Advisors LLC Acquires 105 Shares of Zoetis Inc. (NYSE:ZTS)

Beaumont Financial Advisors LLC grew its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 8.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,415 shares of the company’s stock after purchasing an additional 105 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in Zoetis were worth $279,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of ZTS. Blue Bell Private Wealth Management LLC grew its position in Zoetis by 222.5% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after purchasing an additional 89 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its position in shares of Zoetis by 430.8% during the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $26,000 after acquiring an additional 112 shares in the last quarter. VitalStone Financial LLC acquired a new stake in shares of Zoetis during the 1st quarter valued at about $37,000. Evermay Wealth Management LLC boosted its position in shares of Zoetis by 439.3% during the 1st quarter. Evermay Wealth Management LLC now owns 151 shares of the company’s stock valued at $25,000 after acquiring an additional 123 shares in the last quarter. Finally, Worth Asset Management LLC acquired a new stake in shares of Zoetis during the 1st quarter valued at about $26,000. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on ZTS shares. Stifel Nicolaus cut their price target on shares of Zoetis from $215.00 to $195.00 and set a “buy” rating for the company in a report on Tuesday, April 2nd. Barclays lifted their price target on shares of Zoetis from $255.00 to $260.00 and gave the company an “overweight” rating in a report on Wednesday, February 14th. Piper Sandler reissued an “overweight” rating and set a $195.00 price target (down from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. The Goldman Sachs Group lifted their price target on shares of Zoetis from $190.00 to $226.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, StockNews.com downgraded shares of Zoetis from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $221.75.

Zoetis Trading Down 4.3 %

Shares of NYSE ZTS opened at $146.50 on Friday. Zoetis Inc. has a 1-year low of $145.80 and a 1-year high of $201.92. The company has a market cap of $67.00 billion, a PE ratio of 28.90, a P/E/G ratio of 2.24 and a beta of 0.85. The company has a current ratio of 3.36, a quick ratio of 2.00 and a debt-to-equity ratio of 1.32. The company has a 50-day moving average of $175.48 and a two-hundred day moving average of $180.09.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.08). The business had revenue of $2.21 billion for the quarter, compared to the consensus estimate of $2.19 billion. Zoetis had a return on equity of 51.25% and a net margin of 27.43%. The company’s quarterly revenue was up 8.5% on a year-over-year basis. During the same period last year, the firm earned $1.15 earnings per share. As a group, equities analysts expect that Zoetis Inc. will post 5.79 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be paid a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date is Thursday, April 18th. Zoetis’s dividend payout ratio (DPR) is 34.12%.

Insider Buying and Selling

In related news, EVP Roxanne Lagano sold 923 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $173.33, for a total transaction of $159,983.59. Following the completion of the sale, the executive vice president now directly owns 15,723 shares of the company’s stock, valued at $2,725,267.59. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders sold a total of 2,209 shares of company stock valued at $371,293 over the last ninety days. Insiders own 0.12% of the company’s stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.